| 000 | 01710 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515200726.0 | ||
| 264 | 0 | _c20100629 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1365-2141 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.2009.08011.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZwaan, Christian M | |
| 245 | 0 | 0 |
_aSalvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cMar 2010 |
||
| 300 |
_a768-76 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAminoglycosides _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGemtuzumab |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aReinhardt, Dirk | |
| 700 | 1 | _aZimmerman, Martin | |
| 700 | 1 | _aHasle, Henrik | |
| 700 | 1 | _aStary, Jan | |
| 700 | 1 | _aStark, Batia | |
| 700 | 1 | _aDworzak, Michael | |
| 700 | 1 | _aCreutzig, Ursula | |
| 700 | 1 | _aKaspers, Gertjan J L | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 148 _gno. 5 _gp. 768-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2009.08011.x _zAvailable from publisher's website |
| 999 |
_c19377919 _d19377919 |
||